cDNA array-CGH profiling identifies genomic alterations specific to stage and <it>MYCN</it>-amplification in neuroblastoma
<p>Abstract</p> <p>Background</p> <p>Recurrent non-random genomic alterations are the hallmarks of cancer and the characterization of these imbalances is critical to our understanding of tumorigenesis and cancer progression.</p> <p>Results</p> <p>...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-09-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/5/70 |